Mahmoud et al. have reviewed the antiproliferative effects of genistein in prostate cancer, which is explainable amongst others by the inhibition of tyrosine kinases or the inhibition of NF-κB, respectively. This evidence concerns the gene NFKB1 and Familial prostate cancer.